Immunophenotypic and genetic characterization of a CD8 positive Mantle Cell Lymphoma in a patient with concomitant Mycosis Fungoides

Abstract:  Mantle cell lymphoma (MCL) is immunophenotypically characterized by cell surface co‐expression of CD19, CD20, CD5, IgM and FMC7. However, the concomitant presence of other antigens distinctive of a particular leukocyte subset, e.g. T‐lymphocytes, is an exceptional finding in MCL. Here, the first case of a blastic MCL in leukaemic phase with aberrant expression of the T‐cell associated antigen CD8 occurring in a patient with concomitant Mycosis fungoides is described. Comprehensive immunophenotypic analysis showed that the MCL cells expressed the typical B‐lymphocytic markers, were CD5 and CD8 positive, but did not express other T‐cell proteins, such as CD2, CD3, CD4, CD7, TCRαβ and TCRγδ. The MCL cells expressed both CD8α and CD8β chains indicating cell surface presence of CD8αβ heterodimers. Intriguingly, expression of the cytotoxic enzymes perforin and granzyme A was detected by RT‐PCR. Cytogenetic and molecular genetic analysis of the lymphoma cells confirmed cyclin D1 overexpression secondary to the t(11;14)(q13;32) chromosomal translocation. Furthermore, trisomy 11, trisomy 14 and extra copies of t(11;14) translocated chromosomes were detected in sub clones of the analyzed MCL cells. Clinically, an aggressive course of disease including cerebral lymphoma involvement was noted in the reported patient. Hence, systematic studies addressing the incidence, biology and clinical behavior of this form of MCL seem to be justified in future.

[1]  Frank Griesinger,et al.  B-cell Chronic Lymphocytic Leukemia with Aberrant CD8 Expression: Genetic and Immunophenotypic Analysis of Prognostic Factors , 2004, Leukemia & lymphoma.

[2]  G. Burg,et al.  Clinicopathological spectrum of mycosis fungoides , 2004, Journal of the European Academy of Dermatology and Venereology : JEADV.

[3]  A. Weng,et al.  Hodgkin disease associated with T-cell non-Hodgkin lymphomas: case reports and review of the literature. , 2004, American journal of clinical pathology.

[4]  D. Reinhardt,et al.  ABC transporter ABCA3 is expressed in acute myeloid leukemia blast cells and participates in vesicular transport. , 2004, Haematologica.

[5]  M Hummel,et al.  Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936 , 2003, Leukemia.

[6]  H. Müller-Hermelink,et al.  VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome. , 2003, Blood.

[7]  Y. Richaud-Patin,et al.  CD8+ chronic lymphocytic leukemia: an extensive characterization of a bizarre hybrid neoplasia , 2003, European journal of haematology.

[8]  K. Steinsson,et al.  Risk of malignancy in an unselected cohort of Icelandic patients with systemic lupus erythematosus , 2003, Lupus.

[9]  P. Anton van der Merwe,et al.  The nature of molecular recognition by T cells , 2003, Nature Immunology.

[10]  C. Listinsky,et al.  Composite mycosis fungoides and B-cell chronic lymphocytic leukemia. , 2002, Annals of diagnostic pathology.

[11]  P. Dubus,et al.  A Comparative Analysis of FISH, RT-PCR, PCR, and Immunohistochemistry for the Diagnosis of Mantle Cell Lymphomas , 2002, Modern Pathology.

[12]  D. Catovsky,et al.  Unusual case of leukemic mantle cell lymphoma with amplified CCND1/IGH fusion gene , 2002, Genes, chromosomes & cancer.

[13]  P. Wiernik,et al.  Systemic lupus erythematosus and B-cell hematologic neoplasm , 2001, Lupus.

[14]  Z. Kaleem,et al.  Aberrant expression of T-cell-associated antigens on B-cell non-Hodgkin lymphomas. , 2001, American journal of clinical pathology.

[15]  D. Isenberg,et al.  Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review. , 2000, Rheumatology.

[16]  Thomas,et al.  B‐cell chronic lymphocytic leukaemia with CD8 expression: report of 10 cases and immunochemical analysis of the CD8 antigen , 1998, British journal of haematology.

[17]  F. Naeim,et al.  CD8-positive mantle cell lymphoma: a report of two cases. , 1998, American journal of clinical pathology.

[18]  S. Asano,et al.  Detection of cyclin D1 (bcl-1, PRAD1) overexpression by a simple competitive reverse transcription-polymerase chain reaction assay in t(11;14)(q13;q32)-bearing B-cell malignancies and/or mantle cell lymphoma. , 1997, Blood.

[19]  K. Foon,et al.  Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy. , 1997, Blood.

[20]  Philip R. Cohen,et al.  Chronic cutaneous lupus erythematosus mimicking mycosis fungoides. , 1995, Journal of the American Academy of Dermatology.

[21]  J. Tomashefski,et al.  Composite cutaneous T-cell lymphoma and small B-cell lymphocytic lymphoma: morphologic, immunologic, and molecular genetic documentation of concurrent lymph node involvement. , 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[22]  F. Coco Hybrid phenotypes and lineage promiscuity in acute leukemia. , 1991 .

[23]  F. Lo Coco Hybrid phenotypes and lineage promiscuity in acute leukemia. , 1991, Haematologica.

[24]  J. Parnes Molecular biology and function of CD4 and CD8. , 1989, Advances in immunology.